DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Jupid | $840,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
Certified by Founder
Lodge
Antiverse
start up
United Kingdom
- Cardiff, Wales
- 03/03/2023
- Unknown
- $3,000,000
Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in weeks.
- Industry Pharmaceutical Manufacturing
- Website https://www.antiverse.io/
- LinkedIn https://www.linkedin.com/company/antiverse/
Related People
Murat TunaboyluFounder
United Kingdom -
Cardiff, Wales
CEO of Antiverse, background in software engineering and bioinformatics. Mid-career developed high-frequency trading systems. After switching to biotech, built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific’s gene synthesis workflows. Co-founded consultancy and biotech companies Svarlight and Antiverse.
Currently focusing on to realise Antiverse’s mission: engineering the future of drug discovery.
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
BioOrbit | $13,334,811 | (May 1, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)